文献速递临床试验与 GCP流行病学与生物统计

Safe South Africa 干预预防青少年男孩 HIV 危险行为与性暴力的随机对照试验:原理与设计

Rationale and design of a randomized controlled trial testing the efficacy of Safe South Africa, an intervention to prevent HIV risk behavior and sexual violence among adolescent boys.
PubMed 文献 · Trials · 2025-12-08

该随机对照试验旨在评估行为干预 Safe South Africa 在 15–17 岁南非公立高中男生中预防 HIV 危险行为与性暴力的效果。研究计划纳入 836 名参与者,按 1:1 随机分配至干预组或常规实践对照组,在 4 个月和 12 个月时与基线比较主要结局。研究假设干预组任何性传播感染(包括 HIV)发生率更低,且性暴力实施频率和对亲密伴侣暴力支持态度的认同减少。

要点

  • Safe South Africa 是面向 15–17 岁南非公立高中男生的行为干预,整合预防 HIV 危险行为与性暴力实施。
  • 试验计划纳入 836 名参与者,按 1:1 随机分配至干预组或常规实践对照组。
  • 主要结局在 4 个月和 12 个月时与基线比较,采用广义估计方程处理重复测量。

核心结论

  • 研究假设行为干预 Safe South Africa 可使随机分配至干预组的青少年男孩任何性传播感染(包括 HIV)发生率更低,并减少性暴力实施频率和对亲密伴侣暴力支持态度的认同。
  • 研究结果将有助于为满足学校环境中青少年需求的 HIV 与暴力整合预防干预补充证据基础。

研究设计与样本

  • 这是一项随机对照试验,比较实验性干预 Safe South Africa 与常规实践对照。
  • 计划纳入 N=836 名参与者,按 1:1 分配比例随机分配至干预组或对照组。
  • 纳入标准为:认同为男孩、年龄 15–17 岁、就读于南非 HIV 和暴力高发社区的公立高中。
  • 参与者须在父母同意后提供书面知情同意。
  • 在 4 个月和 12 个月时与基线比较两组主要结局,采用广义估计方程处理重复测量,以量化干预的短期和长期效果。

关键数值与推荐

  • 在南非,常规实践为不实施干预,因为目前该环境中尚无已被证明可同时降低青少年男孩 HIV 风险和性暴力实施的干预措施。
  • Safe South Africa 是行为干预,采取整合方法预防或减少与获得 HIV 和性传播感染(STI)相关的危险行为以及性暴力实施。
  • 该行为干预针对 15–17 岁青少年男孩按性别和发育阶段定制,并在学校环境中实施。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Rates of HIV acquisition and sexual violence perpetration are pressing public health issues for adolescents in South Africa. The evidence base around interventions that concomitantly address both HIV risk and prevention of sexual violence perpetration needs development. This protocol describes the design and procedures for a randomized controlled trial that investigates the efficacy of a behavioral intervention to address HIV and sexual violence called Safe South Africa. METHODS: Safe South Africa is a behavioral intervention. The intervention takes an integrated approach for preventing or reducing risk behavior related to the acquisition of human immunodeficiency virus (HIV) and sexually transmitted infections (STIs) and the perpetration of sexual violence among adolescents in South Africa. The behavioral intervention is gender and developmentally tailored for adolescent boys aged 15-17 years and delivered in the school setting. The trial will compare the experimental intervention-Safe South Africa-with control of practice as usual. In South Africa, the practice as usual consists of no intervention, as there are currently no existing interventions that have been proven to be efficacious for reducing the risk for HIV and perpetration of sexual violence concurrently with adolescent boys in this setting. The study is based on the hypothesis that the behavioral intervention-Safe South Africa-will result in adolescent boys randomized to the intervention showing (a) a lower incidence of any STI (including HIV) and (b) reductions in sexual violence perpetration frequency and decreased endorsement of intimate partner violence supportive attitudes as compared to the control. N = 836 participants will be randomly assigned to either the intervention group or the control group with an allocation ratio of 1:1. Eligible participants include the following: (1) identification as boys; (2) ages 15-17 years; (3) enrolled at public high schools in South Africa situated in communities with high rates of HIV and violence. Participants must provide informed written assent (following parental consent). We will compare primary outcomes between the two study arms at 4 and 12 months versus baseline to quantify the intervention's short- and long-term effects using generalized estimating equations to account for repeated measures. DISCUSSION: Study findings will allow us to contribute to the evidence base of integrated HIV-violence prevention interventions that meet the needs of adolescents in school settings. TRIAL REGISTRATION: This study has been registered at ClinicalTrials.gov under protocol ID NCT03231358. Registered on December 27, 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kuo C, Wasswa J, Orchowski L, et al. Rationale and design of a randomized controlled trial testing the efficacy of Safe South Africa, an intervention to prevent HIV risk behavior and sexual violence among adolescent boys. Trials. 2025. PMID: 41361893. doi:10.1186/s13063-025-09326-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。